Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
23.12
+0.71 (3.17%)
Mar 6, 2026, 1:58 PM EST - Market open
Pelthos Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Pelthos Therapeutics stock have an average target of 54.6, with a low estimate of 48 and a high estimate of 60. The average target predicts an increase of 136.16% from the current stock price of 23.12.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pelthos Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $48 | Buy | Initiates | $48 | +107.61% | Feb 27, 2026 |
| Roth Capital | Roth Capital | Strong Buy Maintains $57 → $55 | Strong Buy | Maintains | $57 → $55 | +137.89% | Feb 26, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $57 → $60 | Buy | Maintains | $57 → $60 | +159.52% | Jan 26, 2026 |
| Lake Street | Lake Street | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +116.26% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +159.52% | Dec 3, 2025 |
Financial Forecast
Revenue This Year
17.53M
Revenue Next Year
64.01M
from 17.53M
Increased by 265.15%
EPS This Year
-18.17
from -14.27
EPS Next Year
-9.56
from -18.17
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 19.1M | 67.7M | ||||
| Avg | 17.5M | 64.0M | ||||
| Low | 15.9M | 59.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 286.3% | ||||
| Avg | - | 265.2% | ||||
| Low | - | 240.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -10.95 | -1.10 | ||||
| Avg | -18.17 | -9.56 | ||||
| Low | -23.92 | -15.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.